JCR which has developed a “J-BrainCargoR” technology allowing to transport more substances through the blood-brain barrier has concluded a research agreement with Peptidream to use this technology for the transport of special cyclic peptides to the brain. Cyclic peptide libraries offer high diversity for targeting drugs.
Peptidream news release, February 22, 2016
JCR Pharmaceuticals and Peptidream Co. cooperate on drug transfer to brain